Roger Clarnette

1.1k total citations
11 papers, 306 citations indexed

About

Roger Clarnette is a scholar working on Psychiatry and Mental health, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roger Clarnette has authored 11 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Epidemiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roger Clarnette's work include Dementia and Cognitive Impairment Research (5 papers), Chronic Disease Management Strategies (4 papers) and Alzheimer's disease research and treatments (2 papers). Roger Clarnette is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Chronic Disease Management Strategies (4 papers) and Alzheimer's disease research and treatments (2 papers). Roger Clarnette collaborates with scholars based in Australia, United States and United Kingdom. Roger Clarnette's co-authors include Jonathan K. Foster, Osvaldo P. Almeida, David Bruce, Timothy M. E. Davis, Timothy G. St. Pierre, Ralph N. Martins, Michael J. House, Valerie Grange, D. William Molloy and Rónán Ó’Caoimh and has published in prestigious journals such as Diabetologia, Neuropsychologia and American Journal of Neuroradiology.

In The Last Decade

Roger Clarnette

10 papers receiving 297 citations

Peers

Countries citing papers authored by Roger Clarnette

Since Specialization

Citations

This map shows the geographic impact of Roger Clarnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Clarnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Clarnette more than expected).

Fields of papers citing papers by Roger Clarnette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Clarnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Clarnette. The network helps show where Roger Clarnette may publish in the future.

Co-authorship network of co-authors of Roger Clarnette

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Clarnette. A scholar is included among the top collaborators of Roger Clarnette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Clarnette. Roger Clarnette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease 2026 ·The Journal of Prevention of Alzheimer s Disease ·James W. Kupiec, (unknown), Raymond Scott Turner, Suzanne Hendrix, Craig Mallinckrodt, Arifulla Khan, (unknown), (unknown), Roger Clarnette, (unknown), (unknown), Lindsay H. Burns	0
2	The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases 2024 ·Translational Neurodegeneration ·(unknown), John Mamo, Virginie Lam, Hani Al‐Salami, Armin Mooranian, Gerald F. Watts, Roger Clarnette, Giuseppe Luna, Ryusuke Takechi	9
3	Efficacy of probucol on cognitive function in Alzheimer’s disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study) 2022 ·BMJ Open ·Virginie Lam, Roger Clarnette, Roslyn J. Francis, Michael Bynevelt, Gerald F. Watts, Leon Flicker, Carolyn Orr, Poh Sien Loh, Nicola T. Lautenschlager, (unknown), Jonathan K. Foster, Satvinder S. Dhaliwal, Suzanne Robinson, (unknown), Mauro Vaccarezza, (unknown), Ryusuke Takechi, John Mamo	7
4	Balance on the Brain: a randomised controlled trial evaluating the effect of a multimodal exercise programme on physical performance, falls, quality of life and cognition for people with mild cognitive impairment—study protocol 2022 ·BMJ Open ·Elissa Burton, Keith Hill, Kathryn A. Ellis, Anne‐Marie Hill, (unknown), Rachael Moorin, Joanne McVeigh, Angela Jacques, Kirk I. Erickson, (unknown), Sarah Bernard, Carolyn Orr, (unknown), Roger Clarnette, Melanie L. Clark, (unknown), Nicola T. Lautenschlager	8
5	MEASURING THE EFFECT OF CARERS ON PATIENTS’ RISK OF ADVERSE HEALTHCARE OUTCOMES USING THE CAREGIVER NETWORK SCORE 2016 ·The Journal of Frailty & Aging ·Rónán Ó’Caoimh, Nicola Cornally, Anton Svendrovski, Elizabeth Weathers, Ciara Fitzgerald, Eugene Healy, Emer O’Connell, (unknown), Eileen O’Herlihy, Yue Gao, (unknown), R. O’Sullivan, Patricia Leahy‐Warren, Francesc Orfila, Constança Paúl, Roger Clarnette, D. William Molloy	13
6	Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic 2016 ·International Journal of Geriatric Psychiatry ·Roger Clarnette, Rónán Ó’Caoimh, (unknown), Anton Svendrovski, D. William Molloy	29
7	Inspection time in non-demented older adults with mild cognitive impairment 2006 ·Neuropsychologia ·(unknown), Osvaldo P. Almeida, Leon Flicker, Susan L. Davies, Roger Clarnette, Michael Anderson, Nicola T. Lautenschlager	19
8	Vascular depression in older people with diabetes 2006 ·Diabetologia ·David Bruce, Graham Casey, Wendy A. Davis, Sergio Starkstein, Roger Clarnette, Jonathan K. Foster, (unknown), Osvaldo P. Almeida, Timothy M. E. Davis	33
9	P2–288: Longitudinal quantitative MRI R2 relaxometry in elderly participants reporting memory loss: A useful tool for the monitoring of dementia onset? 2006 ·Alzheimer s & Dementia ·Jonathan K. Foster, Michael J. House, Timothy G. St. Pierre, Ralph N. Martins, Roger Clarnette, (unknown)	1
10	Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. 2006 ·American Journal of Neuroradiology ·Michael J. House, Timothy G. St. Pierre, Jonathan K. Foster, Ralph N. Martins, Roger Clarnette	78
11	Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study 2003 ·Diabetes Research and Clinical Practice ·David Bruce, (unknown), Valerie Grange, Roger Clarnette, Osvaldo P. Almeida, Jonathan K. Foster, (unknown), Timothy M. E. Davis	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact